# bioMérieux S.A. (BMXXY)

> Healthcare · FR · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BMXXY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | € 1.96B | € 226.10M | € 297.30M | € 421.80M | € 4.30B |
| 2025 | € 4.12B | € 402.02M | € 468.80M | € 461.20M | € 4.10B |
| 2024 | € 4.12B | € 447.77M | € 333.08M | € 490.70M | € 4.20B |
| 2023 | € 3.90B | € 379.48M | € 113.65M | € 518.80M | € 3.75B |
| 2022 | € 3.92B | € 493.91M | € 205.73M | € 505.40M | € 3.60B |
| 2021 | € 4.03B | € 716.79M | € 621.27M | € 462.50M | € 3.12B |
| 2020 | € 3.90B | € 506.20M | € 382.15M | € 481.30M | € 2.43B |
| 2019 | € 3.34B | € 340.51M | € 169.01M | € 592.30M | € 2.20B |
| 2018 | € 3.06B | € 324.44M | € 219.33M | € 654.00M | € 1.93B |
| 2017 | € 2.94B | € 305.74M | € 202.63M | € 468.00M | € 1.74B |
| 2016 | € 2.74B | € 233.08M | € 133.53M | € 453.30M | € 1.62B |
| 2015 | € 2.58B | € 145.38M | € 133.93M | € 370.00M | € 1.49B |
| 2014 | € 2.24B | € 177.92M | € 92.45M | € 368.20M | € 1.38B |
| 2013 | € 2.09B | € 216.33M | € 144.04M | € 402.20M | € 1.26B |
| 2012 | € 2.75B | € 235.29M | € 111.34M | € 0 | € 1.52B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.10 |
| Liabilities / Eq | 0.32 |
| Current Ratio | 2.30 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.99 |
| Gross Debt / FCF | 1.36 |

## Other views

- [Metrics](https://sponda.capital/en/BMXXY.md)
- [Charts](https://sponda.capital/en/BMXXY/charts.md)
- [Compare](https://sponda.capital/en/BMXXY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.